To investigate the molecular pathways underlying the core autistic-like symptoms observed in the two ASD models, we probed the mechanistic target of rapamycin (mTOR) pathway, which is dysregulated in FXS mice [69, 70]. This evidence concerns the gene MTOR and fragile X syndrome.